1 Min Read
Aug 31 (Reuters) - VISTIN PHARMA ASA :
* Q2 TOTAL REVENUE AND INCOME NOK 54.1 MILLION VERSUS NOK 54.6 MILLION YEAR AGO
* Q2 EBITDA NOK 12.4 MILLION VERSUS NOK 13.3 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.